Abstract:The lengthy and expensive process of developing new drugs from scratch, coupled with a high failure rate, has prompted the emergence of drug repurposing/repositioning as a more efficient and cost-effective approach. This approach involves identifying new therapeutic applications for existing approved drugs, leveraging the extensive drug-related data already gathered. However, the diversity and heterogeneity of data, along with the limited availability of known drug-disease interactions, pose significant challenges to computational drug design. To address these challenges, this study introduces EKGDR, an end-to-end knowledge graph-based approach for computational drug repurposing. EKGDR utilizes the power of a drug knowledge graph, a comprehensive repository of drug-related information that encompasses known drug interactions and various categorization information, as well as structural molecular descriptors of drugs. EKGDR employs graph neural networks, a cutting-edge graph representation learning technique, to embed the drug knowledge graph (nodes and relations) in an end-to-end manner. By doing so, EKGDR can effectively learn the underlying causes (intents) behind drug-disease interactions and recursively aggregate and combine relational messages between nodes along different multihop neighborhood paths (relational paths). This process generates representations of disease and drug nodes, enabling EKGDR to predict the interaction probability for each drug-disease pair in an end-to-end manner. The obtained results demonstrate that EKGDR outperforms previous models in all three evaluation metrics: area under the receiver operating characteristic curve (AUROC = 0.9475), area under the precision-recall curve (AUPRC = 0.9490), and recall at the top-200 recommendations (Recall@200 = 0.8315). To further validate EKGDR's effectiveness, we evaluated the top-20 candidate drugs suggested for each of Alzheimer's and Parkinson's diseases.

A foundation model for clinician-centered drug repurposing

A foundation model for clinician-centered drug repurposing

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network

Explainable drug repurposing via path based knowledge graph completion

Knowledge Graphs and Explainable AI for Drug Repurposing on Rare Diseases

Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

KG-Predict: A knowledge graph computational framework for drug repurposing

Drug Repurposing Therapeutics Prediction using Hierarchical Graph Neural Network.

Drug Repurposing for Cancer Treatment Through Global Propagation with a Greedy Algorithm in a Multilayer Network

Application of artificial intelligence and machine learning in drug repurposing

Uncovering hidden therapeutic indications through drug repurposing with graph neural networks and heterogeneous data

Knowledge Graphs for drug repurposing: a review of databases and methods

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing

A knowledge graph approach to drug repurposing for Alzheimer's, Parkinson's and Glioma using drug-disease-gene associations

An explainable foundation model for drug repurposing

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing